Pharmacophore-guided in-silico discovery of SIRT1 inhibitors for targeted cancer therapy

Epigenetic modifier, Sirtuin (SIRTs) is a family of seven isoforms (SIRT1‐7) and nicotinamide adenine dinucleotide (NAD+) dependent class III histone deacetylase (HDACs) protein. SIRT1 in association with the p53 protein can regulate crucial cell processes such as glucose metabolism, lipid metabolis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Computational biology and chemistry 2024-12, Vol.113, p.108275, Article 108275
Hauptverfasser:	Sharma, Deepak, Muniyan, Rajiniraja
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticancer Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Deacetylation Drug Discovery Epigenetic modification Histone Deacetylase Inhibitors - chemistry Histone Deacetylase Inhibitors - pharmacology Humans Molecular docking Molecular Docking Simulation Molecular Dynamics Simulation Molecular Structure Neoplasms - drug therapy Neoplasms - metabolism Neoplasms - pathology Pharmacophore Sirtuin Sirtuin 1 - antagonists & inhibitors Sirtuin 1 - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!